Practical Approach Towards The Role of Badranjboya(Mellisa Officinalis) in Dyslipidemia -A Review

Md Sheeraz; MA Quamari; Md Zakir; Abdur rasheed; Ruqaya Qayum; Md Danish; Md Tauseef Alam

Volume : VII, Issue : VI, June - 2018

Practical Approach Towards The Role of Badranjboya(Mellisa Officinalis) in Dyslipidemia -A Review

Md Sheeraz, Ma Quamari, Md Zakir, Abdur Rasheed, Ruqaya Qayum, Md Danish, Md Tauseef Alam

Abstract :

Dyslipidemia is a metabolic disorder of lipid and lipoproteins. Abnormal plasma lipoproteins and deranged lipid metabolism is considered to be the risk factors for the atherosclerosis and it is one of the major cause of cardiovascular morbidity and mortality. It is presumed that by the year 2020 CVDs will be the leading cause of total disease burden globally.

A number of lipid lowering drugs are available, but all of them will have adverse effects ranges from cutaneous flushing to dyspepsia, headache, fatigue, myopathy, rhabdomyolysis and even hepato–renal toxicity and also causes increased fasting blood sugar. So there is a need for alternative treatment.

In Unani literature the description of Dyslipidemia is correlated with the concept of Simane Mufrit (Obesity). A number of single herbs have been described for the management of Dyslipidemia and one of commonly used herb is Bādranjboya (Mellissa officinalis). In order to provide safe and more effective treatment for Dyslipidemia, a meticulous attempt has been made in this review study to explore the utility of the drugBādranjboya (Mellissa officinalis) in the management of Dyslipidemia.